Drug-Induced Diseases: Prevention, Detection, and Management

Drug-Induced Diseases: Prevention, Detection, and Management

by James E. Tisdale
     
 

View All Available Formats & Editions

According to the authors, a drug-induced disease as an unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result…  See more details below

Overview

According to the authors, a drug-induced disease as an unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result of morbidity and/or mortality associated with drug-induced diseases. Despite best efforts to assure that all drugs are safe and effective, millions of patients each year develop drug-induced diseases. Every time a patient presents with a new disease or an exacerbation of an existing condition, someone needs to ask, “Could this be drug-related?”                Now in its second edition, this popular and essential comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. Edited by James E. Tisdale and Douglas A. Miller, with contributions from experts distinguished in their respective specialties, Drug-Induced Diseases is organized logically and is easy to use for pharmacists, physicians, nurses, and pharmacy students alike. Inside you’ll find:

  • Chapters dedicated to each disease state.
  • In-depth tables throughout each chapter.
  • A new section on Drug-Induced dermatologic diseases.
  • New drugs implicated as the cause of specific disease(s).
  • The inclusion of the Levels of Evidence classification scheme for identifying drug-induced diseases.
  • And much more.

Read More

Editorial Reviews

Doody's Review Service
Reviewer: Patrick J McDonnell, Pharm.D.(Temple University School of Pharmacy)
Description: This is a novel book that highlights the unwanted effect of drugs using an organ-specific approach. This organization allows readers to focus more on the disease state versus individually searching out specific agents that may be causing the pathology.
Purpose: The purpose is to provide insight into how certain drugs may actually cause or contribute to different disease states in an organ-specific fashion. It also identifies patient populations at risk, how to manage these iatrogenic diseases, and, at times, avoid them altogether.
Audience: The audience is broad and the book should definitely be of most interest to physicians and pharmacists involved in drug therapy management. Diagnosticians should find the book helpful as iatrogenic drug causation of certain disease states that may go unrecognized are discussed in this book. It is authored by many different pharmacists based on the area of their specialty or interest.
Features: This book first provides a very nice overview of adverse drug reactions in general, definitions, patient populations at risk, reporting systems, etc. Then the book takes the reader on a virtual physical examination from head to toe, highlighting disease states by organ system and the drugs that are most associated with causing or exacerbating pre-existing, co-morbid disease states. Some chapters are more complete than others, as is often seen in multiauthored books, and, of course, the reader shall need to decide if the information is sufficient or if further references need to be explored.
Assessment: There are not too many books that are totally dedicated to adverse drug reactions in a drug-induced, organ-specific format. As a pharmacy educator who teaches a class of the same title, I shall find this book useful as a primary text for my pharmacy students. Very often to encompass such material, individual review of the medical literature is required, but this book certainly summarizes some of the most germane disease states caused by drugs.

Read More

Product Details

ISBN-13:
9781585283231
Publisher:
ASHP
Publication date:
02/11/2010
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
1132
File size:
5 MB

Related Subjects

Meet the Author

James E. Tisdale, PharmD, BCPS, FCCP Dr. Tisdale received his B.Sc. Pharm from the University of Manitoba in 1983 and his Pharm.D. from S.U.N.Y. at Buffalo in 1988. He completed a pharmacy practice residency at the University of Manitoba Health Science Center in 1984 and a Fellowship in Cardiovascular Therapeutics at Hartford Hospital (CT.) from 1988-1990. He is currently Professor of Pharmacy Practice in the Department of Pharmacy Practice Personnel at the Purdue University School of Pharmacy and Pharmaceutical Sciences in Indianapolis, Indiana. Dr. Tisdale’s research interests are in the area of cardiovascular pharmacotherapy, focusing on: mechanisms, risk factors, and management of drug-induced arrhythmias, and drug therapy for prevention and treatment of atrial fibrillation. His research has resulted in the publication of nearly 50 journal articles, 6 book chapters and 40 research abstracts in addition to his co-editorship of Drug-Induced Diseases. Prevention, Detection and Management. Dr. Tisdale’s research has been funded by the American Heart Association, numerous foundations, and the pharmaceutical industry. From 2001-2004, he was a member of the Board of Regents of the American College of Clinical Pharmacy, and from 2008-2009 he was Chair, Clinical Sciences Section, Academy of Pharmaceutical Research and Science, American Pharmacists Association (APhA). Dr. Tisdale is currently President-Elect of the American College of Clinical Pharmacy (ACCP).  Douglas A. Miller, Pharm.D. Dr. Miller is a professor at the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, where he teaches courses dealing with professional practice and patient care. He earned his BS in Pharmacy from The Ohio State University College of Pharmacy and his Pharm.D. from the Philadelphia College of Pharmacy and Science. His pharmacy experience includes practice in community, long term care and hospital settings. For more than 20 years, he led a team that conceptualized and implemented innovative clinical pharmacy services at Detroit’s Henry Ford Hospital. Dr. Miller served as a member of the Michigan Board of Pharmacy for 11 years including two terms as board chair. He has also served as a member of the Board of Trustees of the American Pharmacists Association and the boards of both the Michigan Pharmacists Association and the Michigan Society of Health-System Pharmacists. He is the recipient of several awards and honors including the Annual Alumni Award of the University of the Sciences in Philadelphia and the Distinguished Alumni Award of the Ohio State University College of Pharmacy, the Pharmacist of the Year Award of the Michigan Pharmacists Association, and awards from both ASHP and APhA for outstanding practice in hospital pharmacy. In 1990, 1991, 1995, 2004, and 2007 he was named "Teacher of the Year" at the Wayne State University Applebaum College of Pharmacy and Health Sciences.Dr. Miller is a Fellow of the American Pharmacists Association.

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >